Ethinyl estradiol/Norgestimate

Ethinyl Estradiol/Norgestimate: Drug Information

Ethinyl Estradiol/Norgestimate: Drug Information

Navigation
1. Drug Name
2. Pharmacological Class
3. Mechanism of Action
4. Indications
5. Dosage and Administration
6. Pharmacokinetics
7. Contraindications
8. Warnings and Precautions
9. Side Effects
10. Drug Interactions
11. Pregnancy and Lactation
12. Patient Counseling Information

1. Drug Name

Generic Name

Ethinyl Estradiol/Norgestimate

Brand Name(s)

  • Pakistan: BrandX
  • India: BrandY
  • US: Ortho Tri-Cyclen, Sprintec, Tri-Sprintec
  • UK: Cilest

2. Pharmacological Class

Class

Contraceptive - Estrogen-Progestin Combination

Subclass

Monophasic Oral Contraceptive

3. Mechanism of Action

Ethinyl estradiol and norgestimate act together to inhibit ovulation by suppressing the release of gonadotropins. They also alter the cervical mucus and endometrium, making it difficult for sperm to reach the uterus and for a fertilized egg to implant.

4. Indications

Primary Indications

  • Prevention of pregnancy

Off-label Uses

  • Management of acne in women
  • Regulation of menstrual cycles

5. Dosage and Administration

Standard Dosage

The dosage regimen depends on the specific formulation and brand. Typically, one tablet daily for 21 days, followed by 7 days without tablets (for menstrual bleeding).

Route of Administration

Oral administration

Special Populations

  • Pediatric: Safety and efficacy not established in girls who have not yet started menstruating.
  • Geriatric: Generally not indicated in postmenopausal women.

6. Pharmacokinetics

Absorption

Rapidly absorbed from the gastrointestinal tract.

Distribution

Bioavailability is approximately 65%. Protein binding is high.

Metabolism

Metabolized in the liver.

Excretion

Excreted in the urine and feces.

Half-life

The elimination half-life of ethinyl estradiol is about 24 hours. The elimination half-life of norgestimate is approximately 10 hours.

7. Contraindications

  • Pregnancy
  • History of thromboembolic disorders
  • Undiagnosed abnormal genital bleeding

8. Warnings and Precautions

  • Increased risk of cardiovascular events
  • Increased risk of thromboembolism
  • Increased risk of breast and cervical cancer

9. Side Effects

Common Side Effects

  • Nausea
  • Headache
  • Breast tenderness

Serious Side Effects

  • Thromboembolic events (e.g., deep vein thrombosis, pulmonary embolism)
  • Hypertension
  • Cholestatic jaundice

10. Drug Interactions

Major Interactions

  • Rifampin
  • Barbiturates

Moderate Interactions

  • Antibiotics (e.g., ampicillin, tetracycline)
  • Anticonvulsants (e.g., phenytoin, carbamazepine)

Minor Interactions

  • Ascorbic acid (vitamin C)
  • Acetaminophen

11. Pregnancy and Lactation

Pregnancy Category

Category X - Contraindicated during pregnancy.

Breastfeeding Considerations

Not recommended during breastfeeding due to potential adverse effects on the infant.

12. Patient Counseling Information

  • Take the medication exactly as prescribed.
  • Use additional contraception if vomiting or diarrhea occur.
  • Report any unusual or severe abdominal pain immediately.

Post a Comment

Previous Post Next Post